Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.

Ann Clin Transl Neurol · 2015 · PMC4435707 · PMID 26000325

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The global test for any difference over time among the multiple pathology groups was significant for dAVLT, composite #1 and #2, and marginally significant for ADAS11 and Trails B, with biomarker-positive groups declining faster.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.